Multibax Past Earnings Performance

Past criteria checks 0/6

Multibax's earnings have been declining at an average annual rate of -15%, while the Chemicals industry saw earnings growing at 8.6% annually. Revenues have been growing at an average rate of 0.2% per year.

Key information

-15.0%

Earnings growth rate

-15.0%

EPS growth rate

Chemicals Industry Growth	8.0%
Revenue growth rate	0.2%
Return on equity	-7.7%
Net Margin	-3.4%
Last Earnings Update	31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Multibax makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SET:MBAX Revenue, expenses and earnings (THB Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 23	1,119	-38	86
30 Sep 23	1,282	-62	100
30 Jun 23	1,601	11	107
31 Mar 23	1,878	74	110
31 Dec 22	1,972	123	111
30 Sep 22	1,890	166	107
30 Jun 22	1,731	133	100
31 Mar 22	1,515	89	101
31 Dec 21	1,460	62	101
30 Sep 21	1,463	41	99
30 Jun 21	1,574	65	103
31 Mar 21	1,795	134	107
31 Dec 20	1,883	176	107
30 Sep 20	1,891	182	105
30 Jun 20	1,678	126	106
31 Mar 20	1,504	69	105
31 Dec 19	1,436	51	105
30 Sep 19	1,381	45	107
30 Jun 19	1,470	81	105
31 Mar 19	1,548	94	100
31 Dec 18	1,561	83	103
30 Sep 18	1,634	79	101
30 Jun 18	1,627	53	102
31 Mar 18	1,646	49	100
31 Dec 17	1,654	61	100
30 Sep 17	1,629	60	97
30 Jun 17	1,599	69	94
31 Mar 17	1,521	57	93
31 Dec 16	1,525	58	88
30 Sep 16	1,541	68	88
30 Jun 16	1,613	69	89
31 Mar 16	1,683	86	89
31 Dec 15	1,729	76	90
30 Sep 15	1,772	58	92
30 Jun 15	1,771	45	93
31 Mar 15	1,770	33	93
31 Dec 14	1,748	42	94
30 Sep 14	1,698	48	92
30 Jun 14	1,624	43	91
31 Mar 14	1,542	9	91
31 Dec 13	1,465	10	90
30 Sep 13	1,425	12	84
30 Jun 13	1,456	29	87

Quality Earnings: MBAX is currently unprofitable.

Growing Profit Margin: MBAX is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: MBAX is unprofitable, and losses have increased over the past 5 years at a rate of 15% per year.

Accelerating Growth: Unable to compare MBAX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MBAX is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (10.4%).

Return on Equity

High ROE: MBAX has a negative Return on Equity (-7.65%), as it is currently unprofitable.

Multibax Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

Full year 2023 earnings released: ฿0.20 loss per share (vs ฿0.64 profit in FY 2022)

Second quarter 2023 earnings released: ฿0.10 loss per share (vs ฿0.22 profit in 2Q 2022)

First quarter 2023 earnings released: ฿0.16 loss per share (vs ฿0.09 profit in 1Q 2022)

Full year 2022 earnings released: EPS: ฿0.64 (vs ฿0.33 in FY 2021)

Second quarter 2022 earnings released: EPS: ฿0.22 (vs ฿0.009 loss in 2Q 2021)

First quarter 2022 earnings released: EPS: ฿0.09 (vs ฿0.046 loss in 1Q 2021)

Recent updates

Multibax Public Company Limited, Annual General Meeting, Apr 11, 2024

Multibax Public Company Limited Proposes to Refrain from Dividend Payments for the Operating Results from the Fiscal Year 2023

Full year 2023 earnings released: ฿0.20 loss per share (vs ฿0.64 profit in FY 2022)

Multibax Public Company Limited Announces the Appointment of Mr. Wanchai Limthawornwatthana as Engineering and Maintenance Director

New major risk - Revenue and earnings growth

Multibax Public Company Limited Announces Board Changes, Effective November 1, 2023

New minor risk - Shareholder dilution

Multibax Public Company Limited Omits Cash Dividend for the Period from January 1, 2023 to June 30, 2023

New major risk - Financial position

Second quarter 2023 earnings released: ฿0.10 loss per share (vs ฿0.22 profit in 2Q 2022)

Multibax Public Company Limited Announces Board Changes, Effective July 1, 2023 Onwards

First quarter 2023 earnings released: ฿0.16 loss per share (vs ฿0.09 profit in 1Q 2022)

Upcoming dividend of ฿0.38 per share at 14% yield

Full year 2022 earnings released: EPS: ฿0.64 (vs ฿0.33 in FY 2021)

Less than half of directors are independent

Upcoming dividend of ฿0.12 per share

Second quarter 2022 earnings released: EPS: ฿0.22 (vs ฿0.009 loss in 2Q 2021)

Multibax Public Company Limited Announces Cash Dividend for the Period from January 1, 2022 to June 30, 2022 Payable on September 08, 2022

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: ฿0.09 (vs ฿0.046 loss in 1Q 2021)

Less than half of directors are independent

Upcoming dividend of ฿0.30 per share

Multibax Public Company Limited Approves the Dividend Payment for the Fiscal Year 2021, Payable 6 May 2022

Multibax Public Company Limited, Annual General Meeting, Apr 07, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Multibax Public Company Limited Proposes A Dividend Distribution, Payable on May 6, 2022

First quarter 2021 earnings released: ฿0.05 loss per share (vs ฿0.17 profit in 1Q 2020)

Investor sentiment deteriorated over the past week

Upcoming dividend of ฿0.56 per share

Full year 2020 earnings released: EPS ฿0.92 (vs ฿0.27 in FY 2019)

Multibax Public Company Limited, Annual General Meeting, Apr 08, 2021

New 90-day low: ฿6.60

Third quarter 2020 earnings released: EPS ฿0.31

Market pulls back on stock over the past week

Market bids up stock over the past week

New 90-day high: ฿8.00

New 90-day high: ฿6.80

First half earnings released

New 90-day high - ฿5.30

Revenue & Expenses BreakdownBeta

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Revenue & Expenses Breakdown
Beta